| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | zf-C2H2_6 | PATZ1 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 4.98e-08 | 314 | 132 | 14 | PF13912 |
| Domain | - | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 6.05e-06 | 679 | 132 | 17 | 3.30.160.60 |
| Domain | Liprin | 6.80e-06 | 6 | 132 | 3 | IPR029515 | |
| Domain | Znf_C2H2/integrase_DNA-bd | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 8.05e-06 | 694 | 132 | 17 | IPR013087 |
| Domain | KRAB | ZNF862 ZNF3 ZNF8 ZNF20 ZNF836 ZNF587 ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 9.08e-06 | 358 | 132 | 12 | PS50805 |
| Domain | KRAB | ZNF862 ZNF3 ZNF8 ZNF20 ZNF836 ZNF587 ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 9.08e-06 | 358 | 132 | 12 | PF01352 |
| Domain | KRAB | ZNF862 ZNF3 ZNF8 ZNF20 ZNF836 ZNF587 ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 1.23e-05 | 369 | 132 | 12 | SM00349 |
| Domain | KRAB | ZNF862 ZNF3 ZNF8 ZNF20 ZNF836 ZNF587 ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 1.26e-05 | 370 | 132 | 12 | IPR001909 |
| Domain | zf-C2H2 | PATZ1 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 3.12e-05 | 693 | 132 | 16 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 3.32e-05 | 775 | 132 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 3.42e-05 | 777 | 132 | 17 | PS00028 |
| Domain | Znf_C2H2-like | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 4.63e-05 | 796 | 132 | 17 | IPR015880 |
| Domain | Beta-catenin | 4.96e-05 | 2 | 132 | 2 | IPR013284 | |
| Domain | Znf_C2H2 | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 5.32e-05 | 805 | 132 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | PATZ1 ZNF831 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 5.57e-05 | 808 | 132 | 17 | SM00355 |
| Domain | Ran_BP1 | 7.25e-05 | 12 | 132 | 3 | PF00638 | |
| Domain | RANBD1 | 7.25e-05 | 12 | 132 | 3 | PS50196 | |
| Domain | RanBD | 9.37e-05 | 13 | 132 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 9.37e-05 | 13 | 132 | 3 | IPR000156 | |
| Domain | SAM_2 | 2.38e-04 | 43 | 132 | 4 | PF07647 | |
| Domain | FBOX | 4.96e-04 | 52 | 132 | 4 | SM00256 | |
| Domain | F-box | 1.29e-03 | 67 | 132 | 4 | PF00646 | |
| Domain | HATC_C_dom | 1.35e-03 | 8 | 132 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 1.35e-03 | 8 | 132 | 2 | PF05699 | |
| Domain | SAM_1 | 1.37e-03 | 68 | 132 | 4 | PF00536 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.19e-04 | 17 | 100 | 3 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.19e-04 | 17 | 100 | 3 | MM14907 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.62e-04 | 18 | 100 | 3 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 2.62e-04 | 18 | 100 | 3 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.62e-04 | 18 | 100 | 3 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 2.62e-04 | 18 | 100 | 3 | M27043 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.62e-04 | 20 | 100 | 3 | M27290 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.62e-04 | 20 | 100 | 3 | MM14721 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.62e-04 | 20 | 100 | 3 | MM14991 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 9480752 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 19013515 | ||
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 1.21e-06 | 6 | 138 | 3 | 21618221 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.37e-06 | 8 | 138 | 3 | 21670213 | |
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 12923177 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 9733766 | ||
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 6.00e-06 | 30 | 138 | 4 | 16186258 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.31e-05 | 12 | 138 | 3 | 9624153 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23555187 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21537344 | ||
| Pubmed | GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. | 1.56e-05 | 2 | 138 | 2 | 21467997 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8068691 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23724138 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23099107 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1509266 | ||
| Pubmed | Regulation of endothelial cell adherens junctions by a Ras-dependent signal transduction pathway. | 1.56e-05 | 2 | 138 | 2 | 10403777 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17984222 | ||
| Pubmed | Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions. | 1.56e-05 | 2 | 138 | 2 | 21703193 | |
| Pubmed | Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling. | 1.56e-05 | 2 | 138 | 2 | 24942731 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1639851 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26485505 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16357441 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17906078 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17638904 | ||
| Pubmed | Expression of β-catenin and γ-catenin in maxillary bone regeneration. | 1.56e-05 | 2 | 138 | 2 | 21781455 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29435814 | ||
| Pubmed | Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis. | 1.56e-05 | 2 | 138 | 2 | 17855627 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23233089 | ||
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.70e-05 | 13 | 138 | 3 | 25246029 | |
| Pubmed | CCP110 PCNX3 MYCBP2 SDCCAG8 DNAAF9 FAAP100 PLIN2 ADAMTS10 METTL21A ZSCAN10 RAPGEF3 FHOD1 VCAN ZNF808 DNASE1L1 ACOXL | 2.74e-05 | 1215 | 138 | 16 | 15146197 | |
| Pubmed | CCP110 PPFIA4 TRAPPC8 TUBGCP5 ZNF836 MYO15B ADAMTS9 ZNF286B EIF3A UNC80 | 2.93e-05 | 493 | 138 | 10 | 15368895 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10825188 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9245795 | ||
| Pubmed | Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. | 4.68e-05 | 3 | 138 | 2 | 16936006 | |
| Pubmed | A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. | 4.68e-05 | 3 | 138 | 2 | 23603203 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15023540 | ||
| Pubmed | A role for PAK1 mediated phosphorylation of β-catenin Ser552 in the regulation of insulin secretion. | 4.68e-05 | 3 | 138 | 2 | 33605402 | |
| Pubmed | Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. | 4.68e-05 | 3 | 138 | 2 | 30890410 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 12051676 | ||
| Pubmed | Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. | 4.68e-05 | 3 | 138 | 2 | 9139698 | |
| Pubmed | c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. | 4.68e-05 | 3 | 138 | 2 | 7702605 | |
| Pubmed | Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations. | 4.68e-05 | 3 | 138 | 2 | 15766557 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9762469 | ||
| Pubmed | Three-dimensional structure of the armadillo repeat region of beta-catenin. | 4.68e-05 | 3 | 138 | 2 | 9298899 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21744421 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21383159 | ||
| Pubmed | Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors. | 4.68e-05 | 3 | 138 | 2 | 25233417 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 16823493 | ||
| Pubmed | Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. | 4.68e-05 | 3 | 138 | 2 | 8663237 | |
| Pubmed | The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. | 4.68e-05 | 3 | 138 | 2 | 19805329 | |
| Pubmed | Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice. | 4.68e-05 | 3 | 138 | 2 | 35455470 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 10769211 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21245375 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9110993 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 26730399 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11707392 | ||
| Pubmed | Catenin expression in T1/2 carcinomas of the floor of the mouth. | 4.68e-05 | 3 | 138 | 2 | 15916880 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28479420 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29660231 | ||
| Pubmed | 6.63e-05 | 20 | 138 | 3 | 30596474 | ||
| Pubmed | Systemwide disassembly and assembly of SCF ubiquitin ligase complexes. | 6.92e-05 | 55 | 138 | 4 | 37028429 | |
| Pubmed | USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis. | 7.71e-05 | 21 | 138 | 3 | 32839293 | |
| Pubmed | 8.90e-05 | 181 | 138 | 6 | 37372979 | ||
| Pubmed | CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP. | 8.91e-05 | 22 | 138 | 3 | 34187934 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 11136974 | ||
| Pubmed | Multiple post-translational modifications regulate E-cadherin transport during apoptosis. | 9.33e-05 | 4 | 138 | 2 | 22375065 | |
| Pubmed | Mammalian formin-1 participates in adherens junctions and polymerization of linear actin cables. | 9.33e-05 | 4 | 138 | 2 | 14647292 | |
| Pubmed | Axin directly interacts with plakoglobin and regulates its stability. | 9.33e-05 | 4 | 138 | 2 | 10488109 | |
| Pubmed | Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. | 9.33e-05 | 4 | 138 | 2 | 7876318 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 20371816 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 12644700 | ||
| Pubmed | Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. | 9.33e-05 | 4 | 138 | 2 | 18837082 | |
| Pubmed | Expression of the E-cadherin-catenin complex in patients with pancreatic ductal adenocarcinoma. | 9.33e-05 | 4 | 138 | 2 | 20529828 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 20529814 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 8858175 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 9638336 | ||
| Pubmed | Identification of plakoglobin domains required for association with N-cadherin and alpha-catenin. | 9.33e-05 | 4 | 138 | 2 | 7650039 | |
| Pubmed | Distinct cadherin-catenin complexes in Ca(2+)-dependent cell-cell adhesion. | 9.33e-05 | 4 | 138 | 2 | 7982500 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 30196316 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 9434630 | ||
| Pubmed | β-catenin coordinates with Jup and the TCF1/GATA6 axis to regulate human embryonic stem cell fate. | 9.33e-05 | 4 | 138 | 2 | 28943339 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 24130809 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 11348595 | ||
| Pubmed | CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells. | 9.33e-05 | 4 | 138 | 2 | 26657156 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 24220035 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 20933443 | ||
| Pubmed | The Parkinson's disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. | 9.33e-05 | 4 | 138 | 2 | 27278822 | |
| Pubmed | X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc). | 9.33e-05 | 4 | 138 | 2 | 33903093 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 23222509 | ||
| Pubmed | Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases. | 1.11e-04 | 62 | 138 | 4 | 29103612 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 1.12e-04 | 272 | 138 | 7 | 18187620 | |
| Pubmed | 1.13e-04 | 469 | 138 | 9 | 27634302 | ||
| Pubmed | 1.32e-04 | 25 | 138 | 3 | 29475039 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E PITPNM2 PCNX3 MYCBP2 INPPL1 TASP1 TEP1 FAAP100 ATP13A2 PLEKHG1 TMEM129 ZBED4 NPRL3 DOCK6 | 1.34e-04 | 1105 | 138 | 14 | 35748872 |
| Pubmed | Array MAPPIT: high-throughput interactome analysis in mammalian cells. | 1.49e-04 | 26 | 138 | 3 | 19159283 | |
| Pubmed | Amino-terminal domain of classic cadherins determines the specificity of the adhesive interactions. | 1.55e-04 | 5 | 138 | 2 | 10910767 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 20032304 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 12604612 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 23136403 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 7890674 | ||
| Cytoband | 19p13.2 | 6.53e-06 | 229 | 138 | 7 | 19p13.2 | |
| Cytoband | 19q13.43 | 6.92e-06 | 87 | 138 | 5 | 19q13.43 | |
| Cytoband | 2q37 | 1.12e-04 | 31 | 138 | 3 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | NLRP7 PPFIA3 ZNF8 ZNF836 KIR3DX1 ZSCAN22 ZNF587 ZNF808 ZNF761 EXOC3L2 ZNF543 ZNF417 | 2.70e-04 | 1192 | 138 | 12 | chr19q13 |
| Cytoband | 11p11.12 | 2.80e-04 | 42 | 138 | 3 | 11p11.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 6.30e-04 | 226 | 138 | 5 | chr2q37 | |
| Cytoband | 1p36.2 | 6.85e-04 | 13 | 138 | 2 | 1p36.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 7.64e-04 | 59 | 138 | 3 | chr2q13 | |
| Cytoband | 2q13 | 1.15e-03 | 68 | 138 | 3 | 2q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | PATZ1 ZNF862 ZNF3 ZNF8 ZNF20 ZNF836 ZSCAN10 ZSCAN22 ZNF587 ZFP64 ZNF286B ZNF808 ZNF761 ZNF85 ZNF543 ZNF417 ZNF791 | 1.52e-07 | 718 | 94 | 17 | 28 |
| GeneFamily | Sterile alpha motif domain containing | 1.14e-03 | 88 | 94 | 4 | 760 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-07 | 185 | 138 | 8 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.51e-07 | 191 | 138 | 8 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-07 | 158 | 138 | 7 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-06 | 172 | 138 | 7 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 176 | 138 | 7 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-06 | 176 | 138 | 7 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-06 | 177 | 138 | 7 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 177 | 138 | 7 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-06 | 182 | 138 | 7 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 186 | 138 | 7 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 186 | 138 | 7 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-06 | 189 | 138 | 7 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-06 | 189 | 138 | 7 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-06 | 189 | 138 | 7 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-06 | 190 | 138 | 7 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.15e-05 | 162 | 138 | 6 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 166 | 138 | 6 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 172 | 138 | 6 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 173 | 138 | 6 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 175 | 138 | 6 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 175 | 138 | 6 | 510c46bfd250ef83fcad8f6b01efbcca9d71a9a2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-05 | 176 | 138 | 6 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 179 | 138 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 180 | 138 | 6 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 181 | 138 | 6 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 182 | 138 | 6 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 182 | 138 | 6 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-05 | 184 | 138 | 6 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 185 | 138 | 6 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 185 | 138 | 6 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 2.52e-05 | 186 | 138 | 6 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 186 | 138 | 6 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 188 | 138 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 192 | 138 | 6 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 193 | 138 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.38e-05 | 196 | 138 | 6 | f0b106078212be1d0938f545707a004a1e830857 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.38e-05 | 196 | 138 | 6 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 3.38e-05 | 196 | 138 | 6 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 199 | 138 | 6 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.81e-05 | 141 | 138 | 5 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 152 | 138 | 5 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 152 | 138 | 5 | bffbbdf1047c59e5241c99dc10b36cfe2071aa48 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 152 | 138 | 5 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 152 | 138 | 5 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 138 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 158 | 138 | 5 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.41e-04 | 160 | 138 | 5 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.41e-04 | 160 | 138 | 5 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 160 | 138 | 5 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 162 | 138 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 162 | 138 | 5 | 16d625ac6702f79a83af444d2b3bf6759fd17cf6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 162 | 138 | 5 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 164 | 138 | 5 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 164 | 138 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 165 | 138 | 5 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 166 | 138 | 5 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 167 | 138 | 5 | 9526e2c7673d569d04e0728a2526318e67432e0a | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 168 | 138 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 168 | 138 | 5 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 8066b4c02c97d00034802cff2b39799ef44cc904 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 170 | 138 | 5 | aaf29c2d4de172d366cbfc863bc741941667dde1 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 170 | 138 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 170 | 138 | 5 | 12aa9bdb18f3bf6da2a25984d08fe9497e5570ed | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 170 | 138 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 170 | 138 | 5 | 067657ca7fcf5a0ffbd168b5c4609a30ca508f22 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-04 | 171 | 138 | 5 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 171 | 138 | 5 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 171 | 138 | 5 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 35d09640d5b04fa0bbb1b40d4b8f97da587a5046 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 98cb64e2a768908105701a7a5b58f336036250fd | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.98e-04 | 172 | 138 | 5 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-04 | 172 | 138 | 5 | a53c906539557594ef10368bc29aec4af063fd37 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 173 | 138 | 5 | 9acad7ec70f713fe3db6cef7bbe3b183bf16ae67 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 173 | 138 | 5 | 7713716ec95932b2fac177ce4cfec027b4754cef | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 174 | 138 | 5 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 175 | 138 | 5 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 175 | 138 | 5 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-04 | 176 | 138 | 5 | 8f9d2a763b79cafe26dcbf3dba980d473a0b9873 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 176 | 138 | 5 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-04 | 176 | 138 | 5 | 3b5d12d5c22e32fbe80c3716ff14a7ae5769c165 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 178 | 138 | 5 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 179 | 138 | 5 | 66afd54428e6dcadc3e341faecfde42be4fb5905 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-04 | 179 | 138 | 5 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 179 | 138 | 5 | fa58fa0901eadb170e3d2facb2a3d8c5e624329a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-04 | 180 | 138 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.49e-06 | 193 | 136 | 9 | 4322_UP | |
| Disease | obesity (implicated_via_orthology) | 3.81e-05 | 215 | 125 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | No-Reflow Phenomenon | 5.33e-05 | 3 | 125 | 2 | C0232347 | |
| Disease | Slow-Flow Phenomenon | 5.33e-05 | 3 | 125 | 2 | C2713615 | |
| Disease | triacylglycerol 56:5 measurement | 1.80e-04 | 26 | 125 | 3 | EFO_0010432 | |
| Disease | mean arterial pressure, unipolar depression | 3.36e-04 | 32 | 125 | 3 | EFO_0003761, EFO_0006340 | |
| Disease | hormone measurement | 4.56e-04 | 84 | 125 | 4 | EFO_0004730 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 4.78e-04 | 36 | 125 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | X-11793--oxidized bilirubin measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0800766 | |
| Disease | smoking status measurement, diastolic blood pressure | 5.95e-04 | 159 | 125 | 5 | EFO_0006336, EFO_0006527 | |
| Disease | X-11442 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 6.29e-04 | 9 | 125 | 2 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 7.84e-04 | 10 | 125 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 7.84e-04 | 10 | 125 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | indoleacetate measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0021015 | |
| Disease | X-21448 measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 7.84e-04 | 10 | 125 | 2 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0010219 | |
| Disease | Parkinson Disease, Secondary Vascular | 1.14e-03 | 12 | 125 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 1.14e-03 | 12 | 125 | 2 | C0751415 | |
| Disease | Secondary Parkinson Disease | 1.14e-03 | 12 | 125 | 2 | C0030569 | |
| Disease | p-cresol glucuronide measurement | 1.14e-03 | 12 | 125 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.14e-03 | 12 | 125 | 2 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 1.35e-03 | 13 | 125 | 2 | EFO_0802007 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 1.41e-03 | 52 | 125 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 1.57e-03 | 54 | 125 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.62e-03 | 118 | 125 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | urate measurement, spine bone mineral density | 1.93e-03 | 58 | 125 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 2.05e-03 | 16 | 125 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.32e-03 | 17 | 125 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Parkinson disease | 2.51e-03 | 321 | 125 | 6 | MONDO_0005180 | |
| Disease | angiopoietin-related protein 1 measurement | 2.61e-03 | 18 | 125 | 2 | EFO_0801382 | |
| Disease | cortical thickness | ANKRD13B PITPNM2 MYCBP2 DNAAF9 ATP13A2 ME2 PLEKHG1 NELL1 ADAMTS9 BAZ1A ACKR3 VCAN | 2.76e-03 | 1113 | 125 | 12 | EFO_0004840 |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.90e-03 | 19 | 125 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | age at onset, smoking initiation | 2.90e-03 | 19 | 125 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | skin hydration measurement | 3.55e-03 | 21 | 125 | 2 | EFO_0009586 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.55e-03 | 21 | 125 | 2 | EFO_0022277 | |
| Disease | tissue factor measurement | 3.55e-03 | 21 | 125 | 2 | EFO_0010623 | |
| Disease | attention function measurement | 3.68e-03 | 148 | 125 | 4 | EFO_0007636 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTLLARAVAHHTDCT | 196 | P62195 | |
| RSCVELLHNEALIRH | 126 | P35503 | |
| RLCHQRAASAHRSLL | 46 | A8MU10 | |
| SASALDHVTRLCHRV | 156 | Q2M3D2 | |
| DHVTRLCHRVVANLL | 161 | Q2M3D2 | |
| CTEVSHHISRRLLER | 31 | Q9NRJ3 | |
| RIHLSSETHRSCLLR | 486 | Q8IYX3 | |
| AISDRICIHTNAHVS | 116 | P07858 | |
| ECRLQGAHLTSILSH | 3196 | P13611 | |
| RHLSLCHGLSDLARV | 306 | Q9P2I0 | |
| QHLSRCALRSHLEGS | 426 | Q8WXI3 | |
| ERCLRESQHARHLSS | 31 | A0A3B3IU63 | |
| ESLKRHHASLTLSCR | 526 | Q2M329 | |
| HCSRLRILEPHSALA | 91 | Q5T686 | |
| VAHSRGHVRLARCLE | 796 | O94983 | |
| HRVVLCKSADHRATL | 966 | Q9H324 | |
| VASLSLAHTHRVTLE | 476 | Q9NUZ1 | |
| THRSRLHEICDDIFA | 96 | Q9NRL2 | |
| LRSGEIRSSAHHCLA | 301 | P34972 | |
| AHCHEAERNIALRSS | 186 | P49792 | |
| SLSDTHDRLHCRRCV | 671 | Q92698 | |
| AHCHEAERNIALRSS | 186 | Q99666 | |
| AHCHEAERNIALRSS | 186 | O14715 | |
| LHLSFTHLVCRSAIE | 556 | Q8IVL6 | |
| HLHLRCSVDFTRRTL | 21 | P09960 | |
| TTLGHLECARVLLAH | 56 | Q86YJ7 | |
| GCESHHDRTLARLSV | 1521 | O75147 | |
| TEPAICALRHLTSRH | 461 | P35222 | |
| LHLSNSTCGHERLRV | 331 | Q9UKC9 | |
| HVLSRVCHALRDLVS | 101 | Q5XUX1 | |
| DHRPLLRASCSDIHS | 186 | Q8NGR6 | |
| ISRVLHTLEVLDRHC | 456 | Q86YW9 | |
| LRRAHDAVLTLTRHC | 301 | Q02846 | |
| RAERAEGHLSVLHLC | 261 | Q6PXP3 | |
| RAEISHHISSCDDRS | 61 | Q8WW33 | |
| LLEHLECLVSRHERS | 116 | O75145 | |
| EHLECLVSRHERSLR | 116 | O75335 | |
| LHTHRAMRSCASESL | 891 | Q76MJ5 | |
| SLRAHELHCAVREVL | 51 | Q9BZ68 | |
| HLHRRVNSLCTDDDS | 876 | O43424 | |
| EHLTRSLQHTLCGDL | 1346 | Q9H6A9 | |
| CSHERSIHLFIDSLL | 266 | P06858 | |
| CSLRTHSLEARHKAL | 221 | A6NHA9 | |
| TRCLSEHAPHLLRDA | 26 | Q9NST1 | |
| CLHNLSRRIATVLQH | 141 | Q12980 | |
| SCSRCLHTALHIAEA | 271 | Q63ZY6 | |
| EHLECLVSRHERSLR | 126 | Q13136 | |
| IVTHLTHSCLRSVLE | 301 | Q96RT8 | |
| HLRSIEEILSFQHCR | 616 | Q6NSJ5 | |
| HSLEARHEALSTCVS | 226 | Q8NGP0 | |
| LHASVLRTEPCSRHS | 686 | Q9BZ72 | |
| SSSLADICRAHHAVV | 791 | Q0VG06 | |
| CSRSIHILLGRRDHT | 201 | Q9Y2T6 | |
| VCALRHLTSRHPEAE | 456 | P14923 | |
| LVHAGARVSLRCHSE | 131 | Q9H7L2 | |
| VSASHLLLHVDCNRI | 156 | Q92832 | |
| QTETDRHITLHCLSV | 136 | Q7Z6M3 | |
| LRLSCSDTHHIQLLI | 186 | Q8NGR3 | |
| FATRDRLRSHLACHE | 451 | Q9HBE1 | |
| HLCSNHSVILLACRI | 161 | Q8WXB1 | |
| ALVDLHRSFHTCISR | 341 | Q96JP2 | |
| QIHSCISRHLECLRS | 51 | Q13772 | |
| TSLSHTFHRALDCRL | 501 | Q8N878 | |
| LSALSHLHACQLRVD | 81 | P09105 | |
| AETHRRHTLFCGTLI | 366 | Q9NQ11 | |
| HHDTAVLLTRQDICR | 381 | Q9P2N4 | |
| RKHLTAIDCQHLARS | 6 | Q8NFZ0 | |
| AIDCQHLARSHLAVT | 11 | Q8NFZ0 | |
| RVRSSHHFESVCLDA | 6 | Q96M78 | |
| LHGERCRSLLHTAAA | 231 | P49184 | |
| LLRHCGSRISTIRTH | 1466 | Q96HP0 | |
| SCSRSHRRLSVHHLV | 481 | O43497 | |
| LITHCRVILEEHSTC | 581 | P16383 | |
| RHCDLQVRIDHTSRT | 476 | Q14152 | |
| ISHCNRSEDLDHTAR | 631 | Q9HC77 | |
| LSHVRKRCLSETHGE | 406 | O00257 | |
| SSGLLFSHCRHRSII | 566 | Q5TEA3 | |
| TCRLEHALFTALHVT | 286 | P25106 | |
| HRRRSRTSSACHILI | 376 | O43303 | |
| CLRGAVDHLHFSSRL | 166 | Q86UD3 | |
| RVVSTTCTLACRHLH | 6 | P23368 | |
| RQVTLSDLHCLDLHR | 456 | Q8TBB5 | |
| DVRRHAHSLQCDLSV | 161 | Q9NYC9 | |
| KDTVRRQSLLHHLCS | 851 | Q9Y613 | |
| AGSLARRLHHACDTL | 306 | Q8NFL0 | |
| HLSDVVLRFCITVSH | 76 | O96011 | |
| TARCVDQHRHIERTL | 216 | Q13474 | |
| HHDIDFCIARSLSIL | 631 | Q8N4N8 | |
| LSLHSCHLERISRGA | 86 | Q86YC3 | |
| VCSILRIHTSEGRHR | 221 | Q8NGN4 | |
| GILASRCLHVDLLHS | 1041 | P33527 | |
| ERVCSLLTSHRAQLH | 346 | Q8N4H0 | |
| HCQLRSVSQEIHRLS | 266 | O60522 | |
| TIDHQSCSRVHAALV | 61 | Q12972 | |
| AHTVLAASCARHRRS | 96 | Q8WUY1 | |
| QSCIHLLSEAHLLVR | 516 | Q969F9 | |
| LREHASRSIHQLTCA | 21 | Q86SQ7 | |
| ESSRTHSLAVSLHCA | 246 | Q9NVX7 | |
| VLRSLRVRHCHHVAE | 246 | Q9H469 | |
| RVRHCHHVAESSLSR | 251 | Q9H469 | |
| TEVSRCIAHLHRTEL | 436 | Q9NWH9 | |
| HLTRTLATSCRRLHS | 206 | O15357 | |
| SAEALRCHLRDHVNV | 136 | P15907 | |
| RSLHSLGRLEHAFCT | 186 | Q9BV20 | |
| SVRILCDHVTRSTCH | 691 | Q8WX94 | |
| TTRSHAALHILGCLD | 1186 | O75592 | |
| SHLHEDSQVARISTC | 871 | O95398 | |
| SRTSSLTCHRRLHTG | 616 | Q86XN6 | |
| IRASSCREHERTHTI | 516 | P17024 | |
| SCNLLRHLLVHTGAR | 681 | Q96SZ4 | |
| ALSCSSSLRVHERIH | 196 | Q3KP31 | |
| SCSSALILHRRIHTG | 266 | P17036 | |
| LHHSRSCARLVRAIK | 1486 | Q8N2C7 | |
| NIHLTHSLEECLVRT | 341 | P98170 | |
| CNLLRVGISSRHHEL | 531 | Q99973 | |
| RFSALLSDCVRHLNH | 186 | Q9BZQ8 | |
| HSSRSHAIFVITIEC | 211 | O15066 | |
| ECSSLIKHRRIHTGE | 531 | Q96SQ5 | |
| AARRILAVAHSHSSL | 111 | Q4KMG9 | |
| ECSSLIKHRRIHTGE | 531 | Q8TAU3 | |
| ASRDECRIHLSHFSL | 216 | Q8IV45 | |
| RSCVELLHNEALIRH | 126 | P35504 | |
| TFSRRSSLLCHRRLH | 491 | Q8N4W9 | |
| ALHRHTRLLCSRRDT | 146 | Q93038 | |
| AHRLHLAVVDACGSI | 726 | O60290 | |
| AFSDCSALIRHLRIH | 416 | P10073 | |
| HRTVFTRAIEACDLH | 511 | Q9HCJ5 | |
| FCRSANLIRHSIIHT | 516 | Q08ER8 | |
| TTCLFLHLRTHTEER | 381 | P17098 | |
| HGACLTLTDHDRIRQ | 336 | Q9Y2L5 | |
| ISCLTEHSRIHTRVN | 186 | Q03923 | |
| HCAEHIESRTLAIAR | 301 | Q99541 | |
| CSSSLIRHQRVHTEE | 506 | P0CG31 | |
| QLLSLHRSSRCESHQ | 1206 | Q9ULL1 | |
| FHLRRTAATLLCHSL | 51 | A0AVI4 | |
| LCLLCSSSQEHRDHR | 111 | A6NDI0 | |
| SSNCSITREHICVHR | 411 | Q9BXT5 | |
| DSHRIHRLCMGSTLA | 1071 | Q5JPB2 | |
| HLVRTILARECSHAL | 296 | Q9H6P5 | |
| SAAALRVHSRVHCKD | 506 | Q9NTW7 | |
| SENSCLVRHLRIHTG | 536 | Q6ZNA1 | |
| VSHLVLVTRNACHLT | 166 | Q9Y2Y6 | |
| LLRDSHVLHSRLSQC | 36 | P40225 | |
| DLSTSCLMRHVRRAH | 151 | O75132 |